MedPath

Serum trypsin as an early predictor of post-endoscopic retrograde pancreatography pancreatitis

Not Applicable
Conditions
patients who wil be plaining to undergo ERCP
Registration Number
JPRN-UMIN000053314
Lead Sponsor
Wakayama Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
147
Inclusion Criteria

Not provided

Exclusion Criteria

they had acute pancreatitis, defined as two of the following three features: (1) abdominal pain consistent with acute pancreatitis (acute onset of persistent, severe, epigastric pain often radiating to the back); (2) pancreatic enzyme activity at least the upper limit of normal; and (3) characteristic findings of acute pancreatitis on computed tomography(CT), magnetic resonance imaging or transabdominal ultrasound

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the diagnostic ability of serum of tripsin levels immediately after (0h-TRY) and 2 hours after (2h-TRY) ERCP to predict PEP.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath